You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Les traitements par chimiothérapie et autres traitements systémiques pourraient être modifiés en raison de la COVID-19. Vous trouverez de plus amples renseignements à la page Traitements systémiques pendant la pandémie de la COVID-19.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Que contient le nouveau formulaire de médicaments

Vous trouverez ici toutes les monographies de médicaments et de régimes nouvelles et mises à jour, ainsi que les fiches de renseignements sur les patients ajoutées au formulaire de médicaments au cours des 30 derniers jours.

Regimen

Published Date: 08 Dec 2021

Cancer Type: Hematologic, Leukemia - Acute Myeloid (AML)
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Dec 2021
Regimen

Published Date: 02 Dec 2021

Cancer Type: Breast
Intent: Curative, Adjuvant
Revision Summary:

Regimen Monograph: Added Febrile neutropenia risk info

Updated
Dec 2021
Regimen

Published Date: 02 Dec 2021

Cancer Type: Gynecologic, Germ Cell
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Febrile neutropenia risk section

Updated
Dec 2021
Regimen

Published Date: 02 Dec 2021

Cancer Type: Breast
Intent: Neoadjuvant, Adjuvant
Revision Summary:

Regimen Monograph: Updated dosing schedule in Drug Regimen, Premedications and supportive care sections

Updated
Dec 2021
Regimen

Published Date: 02 Dec 2021

Cancer Type: Gynecologic, Endometrial
Intent: Adjuvant, Palliative
Revision Summary:

Regimen Monograph: Updated Febrile neutropenia risk to moderate

Updated
Dec 2021
Regimen

Published Date: 02 Dec 2021

Cancer Type: Genitourinary, Bladder / Urothelial
Intent: Neoadjuvant, Adjuvant, Palliative
Revision Summary:

Regimen Monograph: Modified Febrile neutropenia risk section

Updated
Dec 2021
Regimen

Published Date: 02 Dec 2021

Cancer Type: Breast
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Febrile neutropenia risk section

Updated
Dec 2021
Drug

Published Date: 02 Dec 2021

Revision Summary:
Drug Monograph: Updated Dosing, Administration Guidelines and Special Precautions sections
Updated
Dec 2021
Drug

Published Date: 02 Dec 2021

Revision Summary:
Drug Monograph: Updated Dosing and Special Precautions sections
Updated
Dec 2021
Drug

Published Date: 01 Dec 2021

Revision Summary:


Drug Monograph: New Drug Monograph
Patient Info Sheet EN: New information sheet

Updated
Dec 2021
Drug

Published Date: 01 Dec 2021

Revision Summary:
Drug Monograph: Added reference to alternate schedule in Dosing and Monitoring sections
Updated
Dec 2021
Regimen

Published Date: 01 Dec 2021

Cancer Type: Hematologic, Lymphoma - T-cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Added alternate schedule information to Drug regimen; modified Cycle frequency, Dose modification and Monitoring sections

Updated
Dec 2021